Integrated BioPharma, Inc. (INBP)
OTCMKTS · Delayed Price · Currency is USD
0.2675
-0.0125 (-4.46%)
Jun 5, 2025, 3:54 PM EDT

Revenue by Product

Fiscal year is July - June.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2017 - 2019
Contract Manufacturing
48.57M
Log In
Log In
Log In
Log In
Upgrade
Contract Manufacturing Growth
0.60%
Log In
Log In
Log In
Log In
Upgrade
Other Nutraceutical Businesses
1.75M
Log In
Log In
Log In
Log In
Upgrade
Other Nutraceutical Businesses Growth
-26.97%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is July - June.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2017 - 2019
United States
42.34M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-0.64%
Log In
Log In
Log In
Log In
Upgrade
International
7.97M
Log In
Log In
Log In
Log In
Upgrade
International Growth
-1.02%
Log In
Log In
Log In
Log In
Upgrade